Ligand Pharmaceuticals Incorporated

NASDAQ

LGND

Promoção

Lucratividade por seis meses: -4.53%
Rendimento de dividendos: 0%
Setor: Healthcare

Notícias

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

24 julho 11:00 Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - Ligand Pharmaceuticals ( NASDAQ:LGND )

24 julho 11:00 Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - Ligand Pharmaceuticals ( NASDAQ:LGND )

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™

10 julho 12:00 Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

2 julho 11:00 Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics - Ligand Pharmaceuticals ( NASDAQ:LGND )

2 julho 11:00 Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics - Ligand Pharmaceuticals ( NASDAQ:LGND )

Ligand to Participate in May Investor Conferences - Ligand Pharmaceuticals ( NASDAQ:LGND )

1 poderia 11:00 Ligand to Participate in May Investor Conferences - Ligand Pharmaceuticals ( NASDAQ:LGND )

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

17 abril 10:00 Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics - Ligand Pharmaceuticals ( NASDAQ:LGND ) , Channel Therapeutics ( AMEX:CHRO )

17 abril 10:00 Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics - Ligand Pharmaceuticals ( NASDAQ:LGND ) , Channel Therapeutics ( AMEX:CHRO )

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Ligand Pharmaceuticals ( NASDAQ:LGND ) , MannKind ( NASDAQ:MNKD )

10 abril 13:00 This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Ligand Pharmaceuticals ( NASDAQ:LGND ) , MannKind ( NASDAQ:MNKD )

Ligand to Participate in March Investor Conferences - Ligand Pharmaceuticals ( NASDAQ:LGND )

3 martha 12:00 Ligand to Participate in March Investor Conferences - Ligand Pharmaceuticals ( NASDAQ:LGND )